Literature DB >> 17661029

Pre- and post-synaptic sympathetic function in human hibernating myocardium.

Anna S John1, Marco Mongillo, Christophe Depre, Muhammad T Khan, Ornella E Rimoldi, John R Pepper, Gilles D Dreyfus, Dudley J Pennell, Paolo G Camici.   

Abstract

PURPOSE: Impaired pre-synaptic noradrenaline uptake-1 mechanism has been reported in a swine model of hibernating myocardium (HM). To ascertain whether adrenergic neuroeffector abnormalities are present in human HM, we combined functional measurements in vivo using cardiovascular magnetic resonance (CMR) and positron emission tomography (PET) to assess pre- and post-synaptic sympathetic function.
METHODS: Twelve patients with coronary artery disease and chronic left ventricular (LV) dysfunction underwent CMR at baseline and 6 months after bypass for assessment of regional and global LV function and identification of segments with reversible dysfunction. Before surgery, myocardial noradrenaline uptake-1 ([(11)C]meta-hydroxy-ephedrine; HED) and beta-adrenoceptor (beta-AR) density ([(11)C]CGP-12177) were measured with PET. Patient PET data were compared with those in 18 healthy controls.
RESULTS: The volume of distribution (V(d)) of HED in HM (47.95+/-28.05 ml/g) and infarcted myocardium (42.69+/-25.76 ml/g) was significantly reduced compared with controls (66.09+/-14.48 ml/g). The V(d) of HED in normal myocardium (49.93+/-20.48 ml/g) of patients was also lower than that in controls and the difference was close to statistical significance (p=0.06). Myocardial beta-AR density was significantly lower in HM (5.49+/-2.35 pmol/g), infarcted (4.82+/-2.61 pmol/g) and normal (5.86+/-1.81 pmol/g) segments of patients compared with healthy controls (8.61+/-1.32 pmol/g).
CONCLUSION: Noradrenaline uptake-1 mechanism and beta-AR density are reduced in the myocardium of patients with chronic LV dysfunction and evidence of HM. The increased sympathetic activity to the heart in these patients is a generalised rather than regional phenomenon which is likely to contribute to the remodelling process of the whole LV rather than playing a causative role in HM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17661029     DOI: 10.1007/s00259-007-0507-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  31 in total

1.  Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method.

Authors:  J Delforge; A Syrota; J P Lançon; K Nakajima; C Loc'h; M Janier; J M Vallois; J Cayla; C Crouzel
Journal:  J Nucl Med       Date:  1991-04       Impact factor: 10.057

2.  Cardiac sympathetic nerve function in congestive heart failure.

Authors:  G Eisenhofer; P Friberg; B Rundqvist; A A Quyyumi; G Lambert; D M Kaye; I J Kopin; D S Goldstein; M D Esler
Journal:  Circulation       Date:  1996-05-01       Impact factor: 29.690

3.  Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound.

Authors:  Italo Porto; Joseph B Selvanayagam; William J Van Gaal; Francesco Prati; Adrian Cheng; Keith Channon; Stefan Neubauer; Adrian P Banning
Journal:  Circulation       Date:  2006-08-07       Impact factor: 29.690

4.  Regional 11C-hydroxyephedrine retention in hibernating myocardium: chronic inhomogeneity of sympathetic innervation in the absence of infarction.

Authors:  Andrew J Luisi; Gen Suzuki; Robert Dekemp; Michael S Haka; Steven A Toorongian; John M Canty; James A Fallavollita
Journal:  J Nucl Med       Date:  2005-08       Impact factor: 10.057

5.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

6.  Effects of off-pump versus on-pump coronary surgery on reversible and irreversible myocardial injury: a randomized trial using cardiovascular magnetic resonance imaging and biochemical markers.

Authors:  Joseph B Selvanayagam; Steffen E Petersen; Jane M Francis; Matthew D Robson; Attila Kardos; Stefan Neubauer; David P Taggart
Journal:  Circulation       Date:  2004-01-19       Impact factor: 29.690

Review 7.  A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina.

Authors:  S H Rahimtoola
Journal:  Circulation       Date:  1985-12       Impact factor: 29.690

8.  Uptake-1 carrier downregulates in parallel with the beta-adrenergic receptor desensitization in rat hearts chronically exposed to high levels of circulating norepinephrine: implications for cardiac neuroimaging in human cardiomyopathies.

Authors:  Karine Mardon; Olivier Montagne; Nathalie Elbaz; Zoulikha Malek; André Syrota; Jean-Luc Dubois-Randé; Michel Meignan; Pascal Merlet
Journal:  J Nucl Med       Date:  2003-09       Impact factor: 10.057

9.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

10.  Age-dependent changes of cardiac neuronal noradrenaline reuptake transporter (uptake1) in the human heart.

Authors:  Kirsten Leineweber; Thekla Wangemann; Christine Giessler; Heike Bruck; Stefan Dhein; Martin Kostelka; Friedrich Wilhelm Mohr; Rolf Edgar Silber; Otto Erich Brodde
Journal:  J Am Coll Cardiol       Date:  2002-10-16       Impact factor: 24.094

View more
  7 in total

Review 1.  Facts and figures on CAD assessment with SPECT and PET-CT.

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-02       Impact factor: 9.236

2.  Assessing the activity of cardiac sympathetic innervation with a novel PET tracer.

Authors:  Ornella Rimoldi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12       Impact factor: 9.236

Review 3.  Recent Advances and Clinical Applications of PET Cardiac Autonomic Nervous System Imaging.

Authors:  Nabil E Boutagy; Albert J Sinusas
Journal:  Curr Cardiol Rep       Date:  2017-04       Impact factor: 2.931

Review 4.  Dysinnervated but viable myocardium in ischemic heart disease.

Authors:  James A Fallavollita; John M Canty
Journal:  J Nucl Cardiol       Date:  2010-12       Impact factor: 5.952

Review 5.  Assessment of cardiac autonomic neuronal function using PET imaging.

Authors:  James T Thackeray; Frank M Bengel
Journal:  J Nucl Cardiol       Date:  2013-02       Impact factor: 5.952

6.  Altered sympathetic nervous system signaling in the diabetic heart: emerging targets for molecular imaging.

Authors:  James T Thackeray; Rob S Beanlands; Jean N Dasilva
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-20

Review 7.  PET imaging of the autonomic myocardial function: methods and interpretation.

Authors:  Walter Noordzij; Riemer H J A Slart
Journal:  Clin Transl Imaging       Date:  2015-09-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.